Kelsey Financial’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$202K Hold
10,000
– – 0.16% 62
2026
Q2
$253K Hold
10,000
– – 0.19% 52
2026
Q1
$223K Hold
10,000
– – 0.19% 55
2025
Q4
$267K Buy
+10,000
New +$239K 0.23% 49

Other funds holding ACAD

Kelsey Financial's ACAD Position: Q3 2026 in Review

Kelsey Financial held its Acadia Pharmaceuticals (ACAD) position steady in Q3 2026 at 10,000 shares worth $202K. The position accounts for 0.16% of the portfolio, ranked #62.

Kelsey Financial first reported a position in ACAD in Q4 2025 and has held it in 4 quarters since. The position peaked at $267K in Q4 2025. 351 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.

  • Kelsey Financial held 10,000 shares of Acadia Pharmaceuticals worth $202K as of Q3 2026.
  • Kelsey Financial left its Acadia Pharmaceuticals share count unchanged in Q3 2026.
  • Acadia Pharmaceuticals made up 0.16% of Kelsey Financial's portfolio in Q3 2026, its #62 holding.
  • Kelsey Financial first reported a position in Acadia Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • Kelsey Financial's Acadia Pharmaceuticals position peaked at $267K in Q4 2025.
  • 351 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.

Based on Kelsey Financial's 13F filing for Q3 2026, filed 28 Oct 2026.